Human hepatocyte--a model for toxicological studies. Functional and biochemical characterization
Jazyk angličtina Země Slovensko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
11156444
Knihovny.cz E-zdroje
- MeSH
- 7-alkoxykumarin-O-dealkylasa metabolismus MeSH
- antioxidancia toxicita MeSH
- blokátory kalciových kanálů toxicita MeSH
- buněčné kultury metody MeSH
- časové faktory MeSH
- cytochrom P-450 CYP1A2 metabolismus MeSH
- cytochrom P-450 CYP3A MeSH
- dospělí MeSH
- hepatocyty chemie účinky léků fyziologie MeSH
- inhibitory enzymů toxicita MeSH
- jaterní mikrozomy účinky léků MeSH
- játra účinky léků metabolismus MeSH
- kultivované buňky MeSH
- L-laktátdehydrogenasa metabolismus toxicita MeSH
- lidé středního věku MeSH
- lidé MeSH
- nifedipin toxicita MeSH
- oxygenasy se smíšenou funkcí metabolismus MeSH
- rifampin toxicita MeSH
- silymarin toxicita MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- terc-butylhydroperoxid toxicita MeSH
- testy toxicity metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 7-alkoxykumarin-O-dealkylasa MeSH
- antioxidancia MeSH
- blokátory kalciových kanálů MeSH
- CYP3A protein, human MeSH Prohlížeč
- CYP3A4 protein, human MeSH Prohlížeč
- cytochrom P-450 CYP1A2 MeSH
- cytochrom P-450 CYP3A MeSH
- inhibitory enzymů MeSH
- L-laktátdehydrogenasa MeSH
- nifedipin MeSH
- oxygenasy se smíšenou funkcí MeSH
- rifampin MeSH
- silymarin MeSH
- systém (enzymů) cytochromů P-450 MeSH
- terc-butylhydroperoxid MeSH
Isolated human hepatocytes (HH) are an accepted model for in vitro experiments for testing liver function and xenobiotic metabolism. Preferred over more traditional animal hepatocyte model used in toxicological studies, it is the model of choice when substances undergoing biotransformation in man are investigated. The aim of this study was to optimize isolation and culture conditions for HH primary culture with regard to cell yield, viability, and metabolic activity, and to evaluate the suitability of donor samples for toxicology experiments. Cell viability, total cytochrome P450 (CYP) content, CYP3A4, CYP1A2 activity, and finally mixed ethoxycoumarin-O-deethylase (ECOD) activity were parameters measured in order to characterize the isolated HH. The quality of the primary cultures, stable and functional for a seven-day period following 24 hour stabilization, was assessed by lactate dehydrogenase (LDH) leakage and response to the model toxin tert-butylhydroperoxide (tBH) and to silybinin, a model cytoprotective substance. Based on HH obtained from livers of five multiorgan donors (average age 44.8 years, three males and two females), the individual variability of donors needs to be considered in evaluating cultures focussing on clinical liver tests. Greater sensitivity to toxins and silybinin was found in the hepatocyte culture from one donor with higher aminotransferase activity. In another case, higher serum bilirubin appeared to be linked to higher ECOD activity. Our conclusion is that values of clinical liver tests ought to suggest a healthy organ thus eliminating previous hepatocyte damage, the crucial factor of primary culture stability and functioning.
Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin